Literature DB >> 15459193

Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.

Dirk Saerens1, Jörg Kinne, Eugène Bosmans, Ulrich Wernery, Serge Muyldermans, Katja Conrath.   

Abstract

The importance of the lymphocyte source to generate hybridomas or to construct antibody gene libraries from which to identify potent monoclonal antibodies is understudied. However, the few comparative studies that exist seem to favor the lymph node tissue as a B-cell source. Here the peripheral blood and lymph node lymphocytes of a dromedary immunized with prostate-specific antigen (PSA) have been employed to clone two independent gene banks of the variable domains of heavy-chain antibodies (i.e. the VHHs). Several PSA-specific VHHs were retrieved after panning of these phage-displayed VHH libraries. Some of them were derived from the same B-cell lineage, possibly reflecting the restricted primary repertoire of heavy-chain antibodies. Other binders originated from different B-cell lineages and apparently converged toward a striking homologous amino acid sequence motif in their CDR3. This illustrates the strong somatic hypermutation and stringent antigen-driven selection ongoing in these animals. Although the various antigen binders exhibit a broad range of kinetic rate constants for their interaction with the PSA, leading to equilibrium constants from 70 pM to 100 nM, no significant difference existed between the binders from the two B-cell sources. The VHHs of both libraries were categorized in three groups based on nonoverlapping epitopes. Some of these VHHs could inhibit and others could enhance the proteolytic activity of the antigen. Remarkably, VHHs seem to sense or induce conformational changes on different PSA isoforms, a feature that might be exploited to study the PSA conformational flexibility and to discriminate the stages of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459193     DOI: 10.1074/jbc.M409292200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.

Authors:  Jochen Govaert; Mireille Pellis; Nick Deschacht; Cécile Vincke; Katja Conrath; Serge Muyldermans; Dirk Saerens
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

2.  A new approach to study cellular components associated with a certain protein.

Authors:  A S Vyatchanin; S V Tillib
Journal:  Dokl Biochem Biophys       Date:  2008 Jul-Aug       Impact factor: 0.788

3.  Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses.

Authors:  Ahmed Ghannam; Safa Kumari; Serge Muyldermans; Abdul Qader Abbady
Journal:  Plant Mol Biol       Date:  2015-02-04       Impact factor: 4.076

4.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

5.  Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.

Authors:  Dirk Saerens
Journal:  World J Biol Chem       Date:  2010-07-26

6.  Immunodetection of the recombinant GroEL by the Nanobody NbBruc02.

Authors:  Lubna Abo Assali; Ayman Al-Mariri; Ebtisam Hamad; Abdul Qader Abbady
Journal:  World J Microbiol Biotechnol       Date:  2012-07-05       Impact factor: 3.312

7.  Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.

Authors:  Dean P Staus; Laura M Wingler; Ryan T Strachan; Soren G F Rasmussen; Els Pardon; Seungkirl Ahn; Jan Steyaert; Brian K Kobilka; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2013-12-06       Impact factor: 4.436

8.  Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.

Authors:  Delphine Demeestere; Eline Dejonckheere; Sophie Steeland; Paco Hulpiau; Jurgen Haustraete; Nick Devoogdt; Rielana Wichert; Christoph Becker-Pauly; Elien Van Wonterghem; Sylviane Dewaele; Griet Van Imschoot; Jeroen Aerts; Lutgarde Arckens; Yvan Saeys; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mol Ther       Date:  2016-01-18       Impact factor: 11.454

Review 9.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

10.  Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester.

Authors:  Sanne W A Reulen; Ingrid van Baal; Jos M H Raats; Maarten Merkx
Journal:  BMC Biotechnol       Date:  2009-07-20       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.